GLP-1 Insurance Appeal Guide: When Coverage Is Denied — How to Win

Quick answer: What to do when insurance denies your GLP-1

If your insurance denies coverage for a GLP-1 medication (Wegovy, Zepbound, Mounjaro, or Foundayo), you have the right to appeal. The appeal process involves submitting a formal letter with medical documentation from your provider, demonstrating medical necessity. Many denials are overturned on appeal — especially when the provider documents BMI, weight-related conditions, and prior weight loss attempts. This guide walks you through every step, with template letters and escalation strategies.

If your appeal is unsuccessful or you need treatment while waiting, explore affordable cash-pay options or telehealth programs starting at $99/month. For patients facing financial hardship during the appeals process, WeCloseLoans offers personal loan comparison tools that can help bridge the gap.

Step 1: Understand the denial reason

When your insurance denies GLP-1 coverage, they must provide a written explanation. Common denial reasons include:

Step 2: Gather supporting documentation

Your appeal needs strong medical documentation. Work with your provider to collect:

• BMI documentation: Current height, weight, and BMI calculation
• Weight-related conditions: Diagnosis codes for hypertension, type 2 diabetes, sleep apnea, high cholesterol, cardiovascular disease, or other qualifying conditions
• Prior weight loss attempts: Documentation of diet, exercise, behavioral therapy, or other medications tried
• Medical necessity letter: A letter from your provider explaining why GLP-1 medication is medically necessary for your health
• FDA approval citation: Reference the FDA approval for the specific medication and indication
• Clinical guidelines: Cite professional guidelines (AHA/ACC/ADA 2026 CKM Syndrome Guideline) supporting GLP-1 use

Step 3: Submit the appeal

Submit your appeal in writing to your insurance plan's appeals department. Include:

1. A formal appeal letter (template below)
2. Your provider's medical necessity letter
3. Supporting medical records and documentation
4. FDA approval information for the prescribed medication
5. Clinical guideline citations

Timeline: Standard appeals must be decided within 30 days. Expedited appeals (for urgent medical needs) must be decided within 72 hours.

Step 4: Escalate if denied

If your first appeal is denied, you have further options:

• Second-level appeal: Request a review by a different medical reviewer at the insurance company
• External review: File for an independent external review through your state's insurance commissioner or the Department of Labor (for employer-sponsored plans)
• State insurance commissioner complaint: File a complaint with your state's insurance regulatory body
• Patient advocate: Contact a patient advocacy organization for assistance

External reviews are binding — if the reviewer determines the medication is medically necessary, your insurance must cover it.

Appeal letter template

Strategies to improve appeal success

• Cite cardiovascular benefits: Wegovy is FDA-approved for cardiovascular risk reduction — if you have CV risk factors, emphasize this
• Reference clinical guidelines: The 2026 AHA/ACC/ADA/ASN CKM Syndrome Guideline explicitly supports GLP-1 use
• Document step therapy: Show you've tried and failed other weight loss approaches
• Emphasize medical necessity: Frame weight loss as medical treatment for a diagnosed condition (obesity), not cosmetic
• Be persistent: Many appeals succeed at the second or external review level

Alternatives while appealing

If you need treatment while your appeal is pending:

• Manufacturer savings card: If you have commercial insurance (even without GLP-1 coverage), you may qualify for $25/month — see our PAP guide
• NovoCare self-pay: Wegovy pill from $149/month — see our NovoCare guide
• LillyDirect self-pay: Zepbound from $299/month — see our LillyDirect guide
• Compounded GLP-1: From $99/month through telehealth — see cheapest options

The bottom line

Insurance denials for GLP-1 medications are common but often reversible. The key is understanding the denial reason, gathering strong medical documentation, and persisting through the appeal process. Many patients succeed at the external review stage. While you appeal, affordable cash-pay options ensure you don't have to wait to start treatment.